Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A.

Zayas M, Long G, Madan V, Bartenschlager R.

PLoS Pathog. 2016 Jan 4;12(1):e1005376. doi: 10.1371/journal.ppat.1005376. eCollection 2016 Jan.

2.

Functional characterization of bovine viral diarrhea virus nonstructural protein 5A by reverse genetic analysis and live cell imaging.

Isken O, Langerwisch U, Schönherr R, Lamp B, Schröder K, Duden R, Rümenapf TH, Tautz N.

J Virol. 2014 Jan;88(1):82-98. doi: 10.1128/JVI.01957-13. Epub 2013 Oct 16.

3.
4.

A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.

Liu S, Xiao L, Nelson C, Hagedorn CH.

PLoS One. 2012;7(9):e44965. doi: 10.1371/journal.pone.0044965. Epub 2012 Sep 13. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/2e81c9a3-4700-4869-aee9-f079092c77cd. Hagedorn, Curt [corrected to Hagedorn, Curt H].

5.

New insights regarding HCV-NS5A structure/function and indication of genotypic differences.

Yamasaki LH, Arcuri HA, Jardim AC, Bittar C, de Carvalho-Mello IM, Rahal P.

Virol J. 2012 Jan 12;9:14. doi: 10.1186/1743-422X-9-14.

6.

Prediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection.

Takayama T, Ebinuma H, Tada S, Yamagishi Y, Wakabayashi K, Ojiro K, Kanai T, Saito H, Hibi T; Keio Association for the Study of Liver Diseases.

PLoS One. 2011;6(12):e27223. doi: 10.1371/journal.pone.0027223. Epub 2011 Dec 2.

7.

Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.

Gottwein JM, Jensen TB, Mathiesen CK, Meuleman P, Serre SB, Lademann JB, Ghanem L, Scheel TK, Leroux-Roels G, Bukh J.

J Virol. 2011 Sep;85(17):8913-28. doi: 10.1128/JVI.00049-11. Epub 2011 Jun 22.

8.

Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Liu S, Nelson CA, Xiao L, Lu L, Seth PP, Davis DR, Hagedorn CH.

Antiviral Res. 2011 Jan;89(1):54-63. doi: 10.1016/j.antiviral.2010.11.004. Epub 2010 Nov 12.

9.

Identification of tolerated insertion sites in poliovirus non-structural proteins.

Teterina NL, Lauber C, Jensen KS, Levenson EA, Gorbalenya AE, Ehrenfeld E.

Virology. 2011 Jan 5;409(1):1-11. doi: 10.1016/j.virol.2010.09.028. Epub 2010 Oct 23.

10.

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.

Fridell RA, Qiu D, Wang C, Valera L, Gao M.

Antimicrob Agents Chemother. 2010 Sep;54(9):3641-50. doi: 10.1128/AAC.00556-10. Epub 2010 Jun 28.

11.

High-resolution functional profiling of hepatitis C virus genome.

Arumugaswami V, Remenyi R, Kanagavel V, Sue EY, Ngoc Ho T, Liu C, Fontanes V, Dasgupta A, Sun R.

PLoS Pathog. 2008 Oct;4(10):e1000182. doi: 10.1371/journal.ppat.1000182. Epub 2008 Oct 17.

12.

Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.

Tellinghuisen TL, Foss KL, Treadaway J.

PLoS Pathog. 2008 Mar 21;4(3):e1000032. doi: 10.1371/journal.ppat.1000032.

13.

Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein.

Tellinghuisen TL, Foss KL, Treadaway JC, Rice CM.

J Virol. 2008 Feb;82(3):1073-83. Epub 2007 Nov 21.

14.

Studying hepatitis C virus: making the best of a bad virus.

Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM.

J Virol. 2007 Sep;81(17):8853-67. Epub 2007 May 23. Review. No abstract available.

15.

Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.

Veillon P, Payan C, Le Guillou-Guillemette H, Gaudy C, Lunel F.

World J Gastroenterol. 2007 Feb 28;13(8):1195-203.

Supplemental Content

Support Center